Results were statistically significant although the benefit was derived from an analysis that included just 12 patients treated with CDX-011 and 4 patients treated with investigator's choice chemotherapy.
"12 patients and 4 patients treated". Well it is not serious to discuss these PFS & mOS results unless there were many pts with objective and complete responses.